证券代码：600796 证券简称：钱江生化 公告编号：2025-058 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东会类型和届次 2025年第五次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 浙江钱江生物化学股份有限公司 关于召开2025年第五次临时股东会的通知 召开的日期时间：2025 年 12 月 17 日 10 点 00 分 召开地点：浙江省海宁市海洲街道钱江西路 178 号钱江大厦本公司会议室 (五)网络投票的系统、起止日期和投票时间。 股东会召开日期：2025年12月17日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 12 月 17 日 至2025 年 12 月 17 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 一、董事会会议召开情况 浙江钱江生物化学股份有限公司（以下简称"公司"）十届十五次董事会会 议于 2025 年 12 月 1 日在公司会议室以现场和通讯相结合方式召开。会议通知于 2025 年 11 月 19 日以书面及电子邮件方式发出。会议应到董事九名,实到董事九 名，董事钱宏声先生以通讯方式表决，公司高管人员列席了会议。会议由公司董 事长朱燕刚先生主持，本次会议的召开符合《公司法》及《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过了《关于公司董事会换届选举暨提名第十一届董事会非独立 董事候选人的议案》； 证券代码：600796 股票简称：钱江生化 编号：临 2025-056 浙江钱江生物化学股份有限公司 十届十五次董事会决议公告 公司第十届董事会任期已经届满，根据《公司法》和《公司章程》的相关规 定，公司董事会决定换届选举。第十一届董事会由 9 名董事组成，其中非独立董 事 6 名，独立董事 3 名，董事任期三年，自股东会选举通过之日起计算。 ...

Group 1 - The core viewpoint of the news is that Qianjiang Biochemical has seen a stock price increase of 5.08%, reaching 6.41 yuan per share, with a total market capitalization of 5.555 billion yuan as of the report date [1] - Qianjiang Biochemical, established on October 28, 1993, and listed on April 8, 1997, operates in environmental governance, biomanufacturing, and thermal power generation [1] - The company's main business segments include wastewater treatment (29.75%), engineering construction (21.08%), waste disposal (19.04%), bioproducts (18.06%), water supply (6.70%), thermal power supply (4.51%), and other services (1.87%) [1] Group 2 - Minsheng Jia Yin Fund has a significant holding in Qianjiang Biochemical, with the Minsheng Jia Yin Guozheng 2000 Index Enhanced A fund holding 173,400 shares, representing 0.48% of the fund's net value [2] - The fund has achieved a year-to-date return of 32.45%, ranking 974 out of 4,206 in its category, and a one-year return of 35.83%, ranking 775 out of 3,983 [2] - The fund manager, He Jiang, has a tenure of 14 years and 189 days, with the fund's total asset size at 864 million yuan and a best return of 57.31% during his management [3]

证券日报网讯11月17日晚间，钱江生化（600796）发布公告称，浙江钱江生物化学股份有限公司(以下 简称"公司")分别于2025年10月15日、2025年10月31日召开十届董事会2025年第六次临时会议和2025年 第四次临时股东大会，审议通过了《关于增加经营范围、取消监事会并修订 <公司章程> 的议案》。近 日，公司已办理完成了工商变更登记手续，并取得了浙江省市场监督管理局换发的《营业执照》。 ...

证券代码：600796 股票简称：钱江生化 编号：临 2025—055 法定代表人：朱燕刚 注册资本：捌亿陆仟陆佰伍拾捌万伍仟柒佰陆拾陆元 成立日期：1993 年 10 月 28 日 浙江钱江生物化学股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江钱江生物化学股份有限公司（以下简称"公司"）分别于 2025 年 10 月 15 日、2025 年 10 月 31 日召开十届董事会 2025 年第六次临时会议和 2025 年 第四次临时股东大会，审议通过了《关于增加经营范围、取消监事会并修订<公 司章程>的议案》, 具体内容详见公司在上海证券交易所网站（www.sse.com.cn） 披露的临 2025-049 号公告。 近日，公司已办理完成了工商变更登记手续，并取得了浙江省市场监督管理 局换发的《营业执照》，变更后营业执照具体内容如下： 公司名称：浙江钱江生物化学股份有限公司 统一社会信用代码：913300001429396622 类型：其他股份有限公司（上市） ...

Core Viewpoint - Qianjiang Biochemical (600796) has confirmed the operational status of its solar power projects and is planning additional projects in the renewable energy sector [1] Group 1: Solar Power Projects - The company has successfully completed and put into operation the 3.5MWp solar power project under Changhe Waterworks [1] - The Hongcheng Environmental 1.2MWp solar power project has also been completed and is operational [1] - A new 0.8MWp solar power project associated with the relocation of the Hangzhou Bay New Area sewage treatment plant is expected to be completed by the end of the year [1] - Other solar power projects within the company are still under planning and evaluation [1]

Group 1 - The company Qianjiang Biochemical (600796.SH) has announced the completion and operation of its 1.2MWp photovoltaic project under Hongcheng Environmental Protection, in addition to the 3.5MWp project at Changhe Waterworks [1] - The 3.5MWp distributed photovoltaic project at Changhe Waterworks is expected to generate an annual output of 4 million kWh, saving over 10 million yuan in electricity costs over a 20-year period [3] - The company is planning additional photovoltaic projects, with a 0.8MWp project at the Hangzhou Bay New Area sewage treatment plant expected to be completed by the end of the year [1]

Core Viewpoint - Qianjiang Biochemical (600796.SH) has successfully launched multiple photovoltaic power generation projects, contributing to cost savings and environmental sustainability [1] Group 1: Project Developments - The Changhe Water Affairs 3.5MWp photovoltaic power generation project was completed and operational in March this year [1] - The project has saved 280,000 yuan in electricity costs over four months since its operation [1] - The Hongcheng Environmental 1.2MWp photovoltaic power generation project has also been completed and is operational [1] - An additional 0.8MWp photovoltaic project, associated with the new sewage treatment plant in Hangzhou Bay New Area, is expected to be completed by the end of this year [1]

Core Viewpoint - Qianjiang Biochemical (600796.SH) has successfully launched multiple photovoltaic power generation projects, contributing to cost savings and future project developments [1] Group 1: Project Developments - Changhe Water's 3.5MWp photovoltaic power generation project was completed and operational in March this year, resulting in electricity cost savings of 280,000 yuan over four months [1] - Hongcheng Environmental's 1.2MWp photovoltaic power generation project has also been completed and is now operational [1] - The 0.8MWp photovoltaic project associated with the new sewage treatment plant in Hangzhou Bay New Area is expected to be completed by the end of this year [1]

Core Viewpoint - The company, Zhejiang Qianjiang Biochemical Co., Ltd., is set to hold a third-quarter performance briefing on November 18, 2025, to discuss its operational results and financial status for the third quarter of 2025, allowing investors to engage in a Q&A session [2][3]. Group 1: Meeting Details - The performance briefing will take place on November 18, 2025, from 10:00 to 11:00 AM [4]. - The meeting will be held at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [4][5]. - Investors can submit questions from November 11 to November 17, 2025, through the Roadshow Center's website or via the company's email [2][5]. Group 2: Participants - Key participants in the briefing will include the Chairman and General Manager Zhu Yangang, Board Secretary Lu Pingyan, Chief Financial Officer Ma Yuezhong, and Independent Director Wang Lida [4]. Group 3: Investor Participation - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date and time [4][5]. - The company will address commonly asked questions during the session, ensuring transparency and engagement with investors [3][5]. Group 4: Contact Information - For inquiries, investors can contact the Securities Legal Affairs Department via phone or email [5].